Skip to main content
. 2013 Dec 11;32(1):65–74. doi: 10.1097/HJH.0000000000000008

TABLE 4.

Hazard ratios and 95% confidence intervals of independent predictors of a hypertension diagnosis (young adults, N = 4023)

Variable Unadjusted HR 95% CI P value Adjusted HR 95% CI P value
Patient factors
 Age
  18–24 years 0.77 (0.63–0.95) 0.014 0.76 (0.61–0.95) 0.018
  25–31 years 0.81 (0.70–0.94) 0.004 0.79 (0.68–0.93) 0.004
  32–39 years 1.0 1.0
 Sex
  Female 1.2 (1.03–1.42) 0.023
 Race/ethnicity
  White 0.73 (0.57–0.94) 0.013
  Black 1.1 (0.76–1.5) 0.70
  Other 1.0
 Tobacco use
  Current tobacco use 0.76 (0.62–0.93) 0.007
  Former tobacco use 0.95 (0.79–1.1) 0.61
  Never used tobacco 1.0
  Unknown/missing 1.0 (0.83–1.2) 0.90
 BMI 1.006 (0.999–1.014) 0.11
 Primary spoken language
  English 1.0
  Other 0.59 (0.43–0.79) 0.001
 On Medicaid during baseline or study period 1.2 (0.96–1.4) 0.12
 Comorbid conditions
  Diabetes mellitus 1.6 (1.1–2.3) 0.006
  Anxiety 1.2 (1.0–1.5) 0.049
  ACGa risk score, young index 1.0 (0.97–1.1) 0.38
  Intermittent normal blood pressures in baseline 0.74 (0.63–0.87) <0.001
 JNC 7 Stage of hypertensionb
  Stage 1: 140–159/90–99 mmHg 1.0
  Stage 2: ≥160/100 mmHg 1.8 (1.5–2.1) <0.001
 Study start year
  2008 1.0
  2009 1.1 (0.92–1.3) 0.31
  2010 0.87 (0.71–1.1) 0.21
  2011 0.83 (0.63–1.1) 0.17
 Total ambulatory visit counts, annual mean
  Primary care visits 0.88 (0.79–0.99) 0.036
  Specialty visits 1.0 (0.99–1.1) 0.10
  Urgent care visits 0.94 (0.87–1.0) 0.15
Provider factors
 Primary specialty
  Internal medicine 1.0
  Family medicine/family practice 0.91 (0.76–1.1) 0.26
  Other 0.93 (0.74–1.2) 0.52
 Provider age
  Lowest provider age quartile 1.0
  2nd provider age quartile 1.1 (0.88–1.3) 0.57
  3rd provider age quartile 0.93 (0.75–1.1) 0.47
  Highest provider age quartile 0.97 (0.79–1.2) 0.75
 Provider sex
  Female 1.3 (1.1–1.5) 0.001

CI, confidence interval; HR, hazard ratio.

aACG = Adjusted Clinical Group Case-Mix Assessment System.

bJNC 7 Stage of Hypertension = severity of blood pressure elevation at study entry.